Caricamento...
Overview of Biomarkers and Surrogate Endpoints in Drug Development
There are numerous factors that recommend the use of biomarkers in drug development including the ability to provide a rational basis for selection of lead compounds, as an aid in determining or refining mechanism of action or pathophysiology, and the ability to work towards qualification and use of...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IOS Press
2002
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851644/ https://ncbi.nlm.nih.gov/pubmed/12364809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2002/929274 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|